AAAAAA
Results:
1-14
|
Results: 14
Authors:
Ebrahim, S
Daponte, A
Smith, TH
Tiltman, A
Guidozzi, F
Citation: S. Ebrahim et al., Primary mucinous adenocarcinoma of the vagina, GYNECOL ONC, 80(1), 2001, pp. 89-92
Authors:
Ascierto, PA
Palmieri, G
Strazzullo, M
Daponte, A
Botti, G
Satriano, SMR
Motti, ML
Mozzillo, N
Castello, G
Citation: Pa. Ascierto et al., Low doses interferon-alpha in the treatment of high-risk cutaneous melanoma, ANN ONCOL, 11(4), 2000, pp. 487-490
Authors:
Ebrahim, S
Daponte, A
Guidozzi, F
Citation: S. Ebrahim et al., The impact of free antenatal care on perinatal mortality, INT J GYN O, 71(3), 2000, pp. 205-207
Authors:
Daponte, A
Guidozzi, F
Marineanu, A
Citation: A. Daponte et al., Maternal mortality in a tertiary center after introduction of free antenatal care, INT J GYN O, 71(2), 2000, pp. 127-133
Authors:
Ascierto, PA
Daponte, A
Parasole, R
Perrone, F
Caraco, C
Melucci, MT
Palmieri, G
Napolitano, M
Mozzillo, N
Castello, G
Citation: Pa. Ascierto et al., Intermediate dose recombinant interferon-alpha as second-line treatment for patients with recurrent cutaneous melanoma who were pretreated with low dose interferon, CANCER, 89(7), 2000, pp. 1490-1494
Authors:
Daponte, A
Ascierto, PA
Gravina, A
Melucci, MT
Palmieri, G
Comella, P
Cellerino, R
DeLena, M
Marini, G
Comella, G
Citation: A. Daponte et al., Cisplatin, dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma - A multicenter Phase II study of the Southern Italy Cooperative Oncology Group, CANCER, 89(12), 2000, pp. 2630-2636
Authors:
Ascierto, PA
Palmieri, G
Celentano, E
Parasole, R
Caraco, C
Daponte, A
Chiofalo, MG
Melucci, MT
Mozzillo, N
Satriano, RA
Castello, G
Citation: Pa. Ascierto et al., Sensitivity and specificity of epiluminescence microscopy: evaluation on asample of 2731 excised cutaneous pigmented lesions, BR J DERM, 142(5), 2000, pp. 893-898
Authors:
Ascierto, PA
Palmieri, G
Parasole, R
Daponte, A
Castello, G
Citation: Pa. Ascierto et al., 3-year treatment with recombinant interferon-alpha as adjuvant therapy of cutaneous malignant melanoma, INT J MOL M, 3(3), 1999, pp. 303-306
Authors:
Smith, T
Guidozzi, F
Kadar, N
Van Der Wat, IJ
Daponte, A
Citation: T. Smith et al., Laparascopic port-site recurrence in a patient with adenocarcinoma of the cervix, GYNAEC ENDO, 8(4), 1999, pp. 243-244
Authors:
Comella, P
Daponte, A
Citation: P. Comella et A. Daponte, Comments on: Treatment of metastatic malignant melanoma with dacarbazine plus fotemustine, Seeber, et al., Eur J Cancer 1998, 34, 2129-2131, EUR J CANC, 35(7), 1999, pp. 1163-1164
Authors:
Palmieri, G
Strazzullo, M
Ascierto, PA
Satriano, SMR
Daponte, A
Castello, G
Citation: G. Palmieri et al., Polymerase chain reaction-based detection of circulating melanoma cells asan effective marker of tumor progression, J CL ONCOL, 17(1), 1999, pp. 304-311
Authors:
Daponte, A
Guidozi, F
Tiltman, AJ
Marineanu, A
Taylor, L
Citation: A. Daponte et al., p53 as a prognostic factor for stage III serous adenocarcinoma of the ovary, ANTICANC R, 19(3B), 1999, pp. 2387-2389
Authors:
Daponte, A
Guidozzi, F
Moisuc, D
Marineanu, A
Citation: A. Daponte et al., Management of diabetic pregnant patients in a tertiary center in the developing world, INT J GYN O, 64(2), 1999, pp. 141-146
Authors:
Guidozzi, F
Daponte, A
Citation: F. Guidozzi et A. Daponte, Estrogen replacement therapy for ovarian carcinoma survivors - A randomized controlled trial, CANCER, 86(6), 1999, pp. 1013-1018
Risultati:
1-14
|